Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Simon F. Shakar"'
Autor:
JoAnn Lindenfeld, Eugene E. Wolfel, Norman Gray, Simon F. Shakar, Wayne Minobe, Mihail Calalb, Ronald Zolty, Mark W. Geraci, Brian D. Lowes, Joseph C. Cleveland, Michael Reed, Andreas Brieke, Michael R. Bristow
Publikováno v:
The Journal of Heart and Lung Transplantation. 26:1170-1176
Background Heart failure is associated with reversal to a fetal gene expression pattern of contractile and metabolic genes. Substantial recovery of ventricular function with assist devices is rare. Our goal was to evaluate the effects of assist devic
Autor:
JoAnn Lindenfeld, Geraldine G. Miller, Brian D. Lowes, Marilyn E. Levi, Ronald Zolty, Eugene E. Wolfel, Simon F. Shakar, Robert L. Page
Publikováno v:
Circulation. 111:113-117
Autor:
Eugene E. Wolfel, Ronald Zolty, Marc A. Simon, Simon F. Shakar, Brian D. Lowes, Alastair D. Robertson, Michael R. Bristow, JoAnn Lindenfeld
Publikováno v:
Journal of Cardiac Failure. 10:15-20
Background Peak oxygen consumption (VO 2 ) is an important criterion for listing patients for cardiac transplantation. β-Blockers improve survival without affecting peak VO 2 . We questioned the value of peak VO 2 in predicting outcome in patients t
Autor:
J. A. Lindenfeld, Robert L. Roden, Eugene E. Wolfel, Simon F. Shakar, Patti Larrabee, Edward M. Gilbert, Wayne Minobe, Debra A. Ferguson, Jennifer V. Linseman, Kirk Volkman, Brian D. Lowes, Darrin L. Dutcher, Michael R. Bristow, Alastair D. Robertson, James H Sederberg, Robert A. Quaife, William T. Abraham
Publikováno v:
Molecular Medicine. 8:750-760
BACKGROUND: The most common cause of chronic heart failure in the US is secondary or primary dilated cardiomyopathy (DCM). The DCM phenotype exhibits changes in the expression of genes that regulate contractile function and pathologic hypertrophy. Ho
Autor:
Simon F. Shakar, JoAnn Lindenfeld
Publikováno v:
Current Treatment Options in Cardiovascular Medicine. 16
Most patients admitted to the hospital with ADHF do not achieve adequate relief of signs and symptoms of congestion. Patients with inadequate decongestion are known to be at higher risk of readmission for heart failure and mortality, although it is u
Autor:
Michael R. Bristow, Simon F. Shakar
Publikováno v:
Current Cardiology Reports. 3:224-231
beta-blocking agents are now well established as a cornerstone therapy in mild to moderate heart failure. Patients with more advanced heart failure depend on adrenergic activation to maintain adequate myocardial function. This leads to significant di
Autor:
Simon F. Shakar, JoAnn Lindenfeld
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 31(5)
Solid-phase immunoassays to assess human leukocyte antigens (HLAs) and anti-HLA antibodies are a major advance in transplantation immunology. Currently, they still have some limitations such as the inability to distinguish clinically significant anti
Publikováno v:
Journal of cardiac failure. 17(10)
Heart failure (HF) and benign prostatic hypertrophy (BPH) are two conditions that commonly coexist in men 60 years and older. Carvedilol is the only β-adrenergic blocker approved for HF that also has additional α1-adrenergic blockade. As α1-adrene
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 30(6)
We present a patient with post-pericardial injury syndrome (PPIS) that occurred after implantation of a continuous-flow left ventricular assistance device. Evidence supporting the diagnosis includes radiographic, electrocardiographic, and serologic m
Autor:
Anne Cannon, Simon F. Shakar, Max B. Mitchell, Eugene E. Wolfel, David A. Fullerton, Frederick L. Grover, JoAnn Lindenfeld, Andreas Brieke, Brian D. Lowes, Alastair D. Robertson, Joseph C. Cleveland, David N. Campbell
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 136(3)
Objective Left ventricular assist devices are increasingly used as a bridge to transplantation. It remains unclear whether the use of pretransplant left ventricular assist devices adversely affects short-term survival after cardiac transplantation. M